| Date | Time | Source | Announcement |
|---|---|---|---|
| 07 Jun 2005 | 07:00 AM | Transaction in Own Shares | |
| 06 Jun 2005 | 07:00 AM | Transaction in Own Shares | |
| 02 Jun 2005 | 07:00 AM | Transaction in Own Shares | |
| 01 Jun 2005 | 04:00 PM | Director Shareholding | |
| 01 Jun 2005 | 07:00 AM | Transaction in Own Shares | |
| 31 May 2005 | 07:00 AM | Transaction in Own Shares | |
| 27 May 2005 | 07:00 AM | Transaction in Own Shares | |
| 25 May 2005 | 07:00 AM | Transaction in Own Shares | |
| 24 May 2005 | 07:00 AM | Transaction in Own Shares | |
| 23 May 2005 | 04:30 PM | Director Shareholding | |
| 20 May 2005 | 07:00 AM | Transaction in Own Shares | |
| 17 May 2005 | 07:00 AM | Transaction in Own Shares | |
| 16 May 2005 | 07:00 AM | Transaction in Own Shares | |
| 11 May 2005 | 07:00 AM | Transaction in Own Shares | |
| 10 May 2005 | 07:00 AM | Transaction in Own Shares | |
| 06 May 2005 | 04:15 PM | Director Shareholding | |
| 06 May 2005 | 09:00 AM | AGM Resolutions | |
| 06 May 2005 | 07:00 AM | Transaction in Own Shares | |
| 05 May 2005 | 04:45 PM | Director Shareholding | |
| 04 May 2005 | 07:00 AM | Cerovive | |
| 28 Apr 2005 | 04:55 PM | Result of AGM | |
| 28 Apr 2005 | 10:00 AM | 1st Quarter Results (2 of 2) | |
| 28 Apr 2005 | 10:00 AM | 1st Quarter Results (1 of 2) | |
| 27 Apr 2005 | 09:00 AM | Notice of Results | |
| 07 Apr 2005 | 04:00 PM | Director Shareholding | |
| 01 Apr 2005 | 02:30 PM | Nexium | |
| 31 Mar 2005 | 10:30 AM | Director Shareholding | |
| 29 Mar 2005 | 04:16 PM | Director Shareholding | |
| 29 Mar 2005 | 04:15 PM | Director Shareholding | |
| 23 Mar 2005 | 02:00 PM | Notice of AGM | |
| 21 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
| 18 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
| 17 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
| 15 Mar 2005 | 12:00 PM | Director Shareholding | |
| 14 Mar 2005 | 02:00 PM | Directorate Change | |
| 14 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
| 10 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
| 08 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
| 03 Mar 2005 | 04:00 PM | Holding(s) in Company | |
| 03 Mar 2005 | 04:00 PM | Holding(s) in Company | |
| 02 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
| 01 Mar 2005 | 04:00 PM | Director Shareholding | |
| 28 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 25 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 24 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 23 Feb 2005 | 01:30 PM | Regulatory Approval | |
| 22 Feb 2005 | 11:08 AM | Annual Report and Accounts | |
| 21 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 15 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
| 14 Feb 2005 | 07:00 AM | Transaction in Own Shares |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.